Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Pope Leo XIV calls for urgent climate action and says God’s creation is 'crying out' - 2Knesset FADC extends emergency draft for 280,000 IDF reservists until January 1
- 3Investigate Business Mastercard Choices for Better Rewards and Rewards
- 4‘Everybody Loves Raymond: 30th Anniversary Reunion’ premiere date: How to watch, channel, time, cast and more
- 5A definitive Frozen yogurt Standoff: Which Flavor Rules?
- Catholic influencer shares death of 5-year-old son from 'severe' flu
- Muslim Brotherhood stole half a billion dollars in Gaza donations, Arab sources reveal
- Zelensky warns of imminent massive Russian attack on Ukraine
- Unsold Rams May Be Less expensive Than You Suspect
- The most effective method to Pick the Right Material Organization: Your Definitive Aide
- The World's Dazzling Regular Miracles
- What is a Trump Gold Card? U.S. launches $1 million immigration visas
- Vote in favor of your Favored Travel Movement
- Barry Manilow reveals lung cancer diagnosis and plans to undergo surgery: 'It's pure luck' it was 'found so early'
